COVID-19 Knowledge, Attitudes, and Vaccine Hesitancy in Ethiopia: A Community-Based Cross-Sectional Study.
COVID-19
Ethiopia
attitude
hesitancy
knowledge
vaccine
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
31 Mar 2023
31 Mar 2023
Historique:
received:
02
12
2022
revised:
02
03
2023
accepted:
05
03
2023
medline:
28
4
2023
pubmed:
28
4
2023
entrez:
28
4
2023
Statut:
epublish
Résumé
The current healthcare system's efforts to reduce the spread of COVID-19 in Ethiopia and limit its effects on human lives are being hampered by hesitancy toward the COVID-19 vaccine. The aim of this study was to assess the knowledge levels, attitudes, and prevention practices of COVID-19, in the context of the level of vaccine hesitancy with other associated factors in Ethiopia. A community-based cross-sectional design with mixed-method data sources was employed. It comprised 1361 study participants for the quantitative survey, with randomly selected study participants from the studied community. This was triangulated by a purposively selected sample of 47 key informant interviews and 12 focus group discussions. The study showed that 53.9%, 55.3%, and 44.5% of participants had comprehensive knowledge, attitudes, and practices regarding COVID-19 prevention and control, respectively. Similarly, 53.9% and 47.1% of study participants had adequate knowledge and favorable attitudes toward the COVID-19 vaccine. Only 29.0% of the total survey participants had been vaccinated with at least one dose of vaccine. Of the total study participants, 64.4% were hesitant about receiving the COVID-19 vaccination. The most frequently reported reasons were a lack of trust in the vaccine (21%), doubts regarding the long-term side effects (18.1%), and refusal on religious grounds (13.6%). After adjusting for other confounding factors, geographical living arrangements, the practices of COVID-19 prevention methods, attitudes about the vaccine, vaccination status, perceived community benefit, perceived barriers toward vaccination, and self-efficacy about receiving the vaccine were significantly associated with vaccine hesitancy. Therefore, to improve vaccine coverage and reduce this high level of hesitancy, there should be specifically designed, culturally tailored health education materials and a high level of engagement from politicians, religious leaders, and other community members.
Identifiants
pubmed: 37112686
pii: vaccines11040774
doi: 10.3390/vaccines11040774
pmc: PMC10140841
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Amref Health Africa
ID : R223
Références
Vaccine. 2020 Dec 3;38(51):8090-8098
pubmed: 33187765
PLoS One. 2022 Jan 24;17(1):e0259851
pubmed: 35073320
PLoS Negl Trop Dis. 2020 Sep 4;14(9):e0008700
pubmed: 32886678
PLoS One. 2021 Sep 7;16(9):e0257112
pubmed: 34492089
Vaccines (Basel). 2021 Feb 16;9(2):
pubmed: 33669441
Patient Prefer Adherence. 2021 Feb 15;15:337-348
pubmed: 33623375
Soc Sci Med. 2021 Mar;272:113638
pubmed: 33414032
PLoS One. 2021 Dec 17;16(12):e0261125
pubmed: 34919597
BMJ Open. 2022 May 30;12(5):e052432
pubmed: 35636790
BMC Public Health. 2020 Aug 26;20(1):1292
pubmed: 32847554
Cell Mol Immunol. 2020 May;17(5):555-557
pubmed: 32235915
N Engl J Med. 2020 May 21;382(21):1969-1973
pubmed: 32227757
Hum Vaccin Immunother. 2022 Nov 30;18(6):2114699
pubmed: 36094824
Glob Health Res Policy. 2022 Jul 19;7(1):21
pubmed: 35850783
Curr Med Res Opin. 2020 Dec;36(12):1955-1960
pubmed: 33044091
Nat Med. 2021 Aug;27(8):1338-1339
pubmed: 34272500
Hum Vaccin Immunother. 2022 Nov 30;18(5):2056400
pubmed: 35468306
Hum Vaccin Immunother. 2021 Aug 3;17(8):2575-2577
pubmed: 33705246
SSM Popul Health. 2022 Mar;17:101040
pubmed: 35155727
Vaccines (Basel). 2021 Jan 12;9(1):
pubmed: 33445581
Vaccines (Basel). 2022 Dec 08;10(12):
pubmed: 36560507
Hum Vaccin Immunother. 2021 Dec 2;17(12):4838-4845
pubmed: 35213947
ESMO Open. 2021 Feb;6(1):100027
pubmed: 33399089
Lancet Glob Health. 2022 Mar;10(3):e320-e321
pubmed: 34942117
PLoS One. 2021 Sep 2;16(9):e0255121
pubmed: 34473719
Vaccines (Basel). 2022 Jun 18;10(6):
pubmed: 35746581
Hum Vaccin Immunother. 2022 Dec 31;18(1):1-10
pubmed: 34919494